[1] Wang ZY,Chen Z.Acute promyelocytic leukemia:from highly fatal to highly curable[J].Blood,2008,111(5):2505-2515.
[2] 张之南,沈悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,2007:131-134.
[3] 余和平,陈钰,沈志祥,等.急性早幼粒细胞性白血病患者早期死亡原因探查[J].临床血液学杂志,2002,15(6):254-255.
[4] 黄梓伦.急性早幼粒细胞白血病的治疗现状[J].广东医学,2004,25(8):869-871.
[5] 林武强,郑合勇.全反式维甲酸、三氧化二砷联合高三尖杉酯碱化疗治疗急性早幼粒细胞白血病临床分析[J].中国实用医药,2009,4(24):153-154.
[6] 卢立志,王文英.全反式维甲酸治疗急性早幼粒细胞白血病的现状及若干相关问题[J].现代诊断与治疗,2005,16(2):127-128.
[7] 纪淑仪,傅承斌,王信珙,等.全反式维甲酸和小剂量三尖杉酯碱治疗急性早幼粒细胞白血病[J].中华血液学杂志,1996,17(6):314.
[8] Montesinos P,Bergua JM,Vellenga E,et al.Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retionoic acid and anthracycline chemotherapy:characteristics,outcome,and prognostic factors[J].Blood,2009,113(4):775-783.
[9] Shen Z,Shi Z,Fang J,et al.All-trans retinoic acid/As2O3 combination yield a high quality remission and survival in newly diagnosed acute promyelocytic leukemia[J].Proc Natl Acad Sci USA,2004,101(15):5328-5335.
[10] Estey E,Garcia-Manero G,Ferrajoli A,et al.Use of all-trans rentionic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia[J].Blood,2006,107(9):3469-3473.
[11] Kitamura K,Kiyoi H,Yoshid A H,et al.New retinoids an arsenic compounds for the treatment of refractory acute promyelocytic leukemia:clinical and basic studies for the next generation[J].Cancer Chemother Pharmacol,1997,40(Suppl):S36.
[12] 张鹏,王树叶,胡龙虎,等.三氧化二砷治疗急性早幼粒细胞白血病七年总结:附242例分析[J].中华血液学杂志,2000,21(2):67-70.